Not applicableStudy completedNCT02541058What this trial is testingNon-Invasive Chromosomal Evaluation of 22q11.2Who this might be right for22q.11.2 Deletion/Duplication Cindy Cisneros 420
Not applicableStudy completedNCT02738281What this trial is testingNatural History of Rett Syndrome & Related DisordersWho this might be right forRett SyndromeMECP2 Duplication dIsorderCDKL5 Disorder+1 more University of Alabama at Birmingham 1,044
Not applicableStudy completedNCT00299312What this trial is testingGenetic and Physical Characteristics of Rett SyndromeWho this might be right forRett SyndromeMECP2 Duplication DisorderRett-related Disorder University of Alabama at Birmingham 10
Testing effectiveness (Phase 2)Study completedNCT02984995What this trial is testingPhase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) MutationWho this might be right forLeukemia, Myeloid, Acute Daiichi Sankyo Co., Ltd. 37
Not applicableUnknownNCT04051086What this trial is testingQuantification of Elastin Markers Synthesis in Williams-Beuren Syndrome and 7q11.23 Micro-duplication SyndromeWho this might be right forWilliams-Beuren SyndromeMicro-duplication 7q11.23 SyndromeVasculopathy Hospices Civils de Lyon 90
Not applicableLooking for participantsNCT01132885What this trial is testingDefining the Brain Phenotype of Children With Williams SyndromeWho this might be right forWilliams SyndromeDuplication National Institute of Mental Health (NIMH) 415
Testing effectiveness (Phase 2)Study completedNCT02927262What this trial is testingASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete RemissionWho this might be right forAcute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation Astellas Pharma Global Development, Inc. 98
Not applicableLooking for participantsNCT06930417What this trial is testingCharacterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 VariantsWho this might be right forWilliams Beuren SyndromeWilliams SyndromeWilliams Beuren Region Duplication+1 more University of Pennsylvania 2,000
Not applicableUnknownNCT05596968What this trial is testingThe Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCTWho this might be right forAcute Myeloid Leukemia With FLT3/ITD MutationAllogeneic Hematopoietic Stem Cell Transplantation Nanfang Hospital, Southern Medical University 37
Not applicableActive Not RecruitingNCT03880435What this trial is testingHYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become PregnantWho this might be right forInfertilityPolyp UterusMyoma;Uterus+4 more University Hospital, Ghent 419
Not applicableStudy completedNCT00003931What this trial is testingDiagnostic Study of Gene Alterations in Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 9,769
Not applicableUnknownNCT02617108What this trial is testingIntrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic AdhesiolysisWho this might be right forUterine Septum Fu Xing Hospital, Capital Medical University 310
Not applicableStudy completedNCT04449640What this trial is testingUterine Rupture After Hysteroscopic Septum ResectionWho this might be right forSeptum; UterusRupture, Uterine Università degli Studi dell'Insubria 3,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT05876832What this trial is testingXY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE)Who this might be right forAcute Myeloid Leukemia With FLT3/ITD Mutation Shijiazhuang Yiling Pharmaceutical Co. Ltd 312
Testing effectiveness (Phase 2)Study completedNCT04179409What this trial is testingA 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.Who this might be right forDuchenne Muscular Dystrophy Kevin Flanigan 3
Early research (Phase 1)Active Not RecruitingNCT03513484What this trial is testingNintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2AFibroblast Growth Factor Basic Form MeasurementFLT3 Internal Tandem Duplication+2 more Northwestern University 44
Not applicableStudy completedNCT01572870What this trial is testingDuplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF PatientsWho this might be right forCystic FibrosisChit1 Rambam Health Care Campus 40
Not applicableLooking for participantsNCT02447861What this trial is testingThe 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral PhenotypesWho this might be right forMicrodeletion 3q29 SyndromeMicroduplication 3q29 Syndrome Rutgers, The State University of New Jersey 800
Not applicableNot Yet RecruitingNCT07469566What this trial is testingCharacterization of the Natural History of Microduplication Syndrome 7q11.23Who this might be right for7q11.23 Microduplication Syndrome (7DUP)Autism Spectrum Disorder (ASD)Neurodevelopmental Disorders (NDD) Hospices Civils de Lyon 15
Not applicableStudy completedNCT03077308What this trial is testingRare Diseases Clinical Research Network: Neurophysiological CorrelatesWho this might be right forRett Syndrome, Preserved Speech VariantMecp2 Duplication SyndromeRett-related Disorders University of Alabama at Birmingham 185